Navigation Links
The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care
Date:2/6/2008

New Deloitte Center for Health Solutions study outlines plan to help primary care doctors better manage chronic illnesses, coordinate care

WASHINGTON, Feb. 6 /PRNewswire-USNewswire/ -- Primary care physicians should exert broader control in managing their patients' chronic diseases and be compensated accordingly for their enhanced role in overall care coordination, a new study from the Deloitte Center for Health Solutions (http://www.deloitte.com/centerforhealthsolutions) concludes.

In its study, "The Medical Home: Disruptive Innovation for a New Primary Care Model,"(http://www.deloitte.com/us/medicalhome) the Center outlines a course of comprehensive patient management, starting with primary care doctors and allied professionals providing a range of diagnostic and therapeutic services to improve care coordination.

Medical home is a health care management model in which the primary health care physician serves as a "health coach" for patients, serving as an advocate for patients, and are paid to deliver a higher level of care coordination. The model predicts a reduction in unnecessary tests and hospital visits, and the Center report details potential savings and implications for policy makers and key industry stakeholders.

"Given the clear correlation between runaway health care costs and lack of attention to chronic care, policy makers must think seriously about the medical home as a solution," said Dr. Paul Keckley, executive director of the Deloitte Center for Health Solutions. "It's a logical approach to a persistent problem in U.S. health care."

The objective is to provide patients with a more attentive channel of health care - preventative and acute - over time, while streamlining patient care by leveraging information technology. Expanding the oversight and treatment
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
2. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
3. MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
4. Margaret Dimond Named President and CEO of McLaren Medical Management Inc.
5. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
6. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
7. Greenway Medical Technologies Continues Record Setting Growth
8. ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio
9. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
10. SpringCM Improves Contract Management Efficiency for Medical Staffing Agency
11. Collaboration needed for strengthening medical research in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Soft and synthetic red-blood-cell-like particles carry oxygen, drugs, and more… ... ... -- Scientists at UC Santa Barbara, in collaboration with scientists ... mimic the characteristics and key functions of natural red blood ... , , , , ,The primary function of natural ...
(Date:12/14/2009)... Heska Corporation (Nasdaq: HSKA ; "Heska" ... veterinary diagnostic and specialty products, today announced ... new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the ... ,, Customers receiving these analyzers have invested ... available to the veterinary in-clinic market. ...
(Date:12/14/2009)... Enough To Wear Pink(TM) (TETWP), the grassroots cowboy ... anniversary at the signature Tough Enough To Wear ... (Wrangler NFR) in Las Vegas. While pink is ... support of the western industry and rodeo fans ... shirts, hats, bracelets and more. ,, Through ...
(Date:12/14/2009)... widely and are higher than generally thought, raising concerns about increased ... of California, San Francisco (UCSF) imaging specialists. , ... ... doses from common CT procedures vary widely and are higher than ... a new study led by University of California, San Francisco ...
(Date:12/14/2009)... The Hemophilia Federation of America (HFA) expresses its ... Teamsters Local 929 and the American Red Cross ... depends on skilled workers to provide clean, safe ... products such as clotting factor for use in ... The Division of Blood Services at the American ...
Breaking Medicine News(10 mins):Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:HFA Voices Blood Safety Concerns 2
... Smokers who have a say in how they quit are ... successful, according to new research at the University of Rochester ... of medicine at the University of Rochester School of Medicine ... this month that demonstrate patient involvement in a quit plan ...
... too. Together, they form a difficult pair to beat ... team of Ohio University College of Osteopathic Medicine (OU-COM) ... approach to the double-edged problem. Program ACTIVE (Appalachians Coming ... feasibility study to test the effectiveness of a combination ...
... by Huibert Mansvelder reveals that a stimulating environment can restore ... findings have been published in the May 24, 2007 issue ... ,A type of inherited mental retardation; Fragile X syndrome affects ... females. The researchers carried out studies on mice that were ...
... Dr. Lin Mei report in the May 24 issue ... keep a healthy balance between excitation and inhibition ... in cancer and schizophrenia. ,The research showed ... the site of inhibitory synapses in the brain by ...
... new study in The Journal of Strength and Conditioning ... experience a lowered response to resistance training when ... compared the response to a supervised upper arm, unilateral ... overweight or obese to the response of normal weight ...
... Mark Heiner of Culver City reads books, paints artistically, ... be considered routine except for the fact that ... keeping his blood flowing. ,The procedure to ... March by a team led by cardiothoracic surgeon Sinan ...
Other Medicine News:Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2Health News:Study Tests Depression Treatment for Diabetes Patients 2Health News:Study Tests Depression Treatment for Diabetes Patients 3Health News:Enriching Environment Stimulates Neurons: Hope For Fragile X Syndrome 2Health News:Brain Cells Activity: New Treatment Target for Psychiatric Diseases 2Health News:Brain Cells Activity: New Treatment Target for Psychiatric Diseases 3Health News:Heart-Assist Device Gives Culver City Man a Good Quality of Life 2Health News:Heart-Assist Device Gives Culver City Man a Good Quality of Life 3
(Date:12/14/2009)... THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ ... investigators affiliated with US Oncology ... were presented orally at the ... , held Dec. 9-13 at the ... in San Antonio, Texas . ...
(Date:12/14/2009)... Cardinal Health today announced that executives of ... ,, Goldman Sachs CEO Unplugged Conference ... Sachs Conference Center in New York. 28th ... at Noon EST at the Westin St. Francis Hotel ... executives will discuss Cardinal Health,s diverse products and services, ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that provides ... announce that its affiliated fund has closed a private ... equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... growth of Imaging Diagnostic Systems, Southridge has paved a ... the field of early breast cancer detection," said Stephen ...
Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Cardinal Health Executives to Speak at Two Investor Events in January 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 1Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 2Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 3Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 4Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 1Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 2Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 3Genova files patent for new prostate cancer treatment 56395 1Genova files patent for new prostate cancer treatment 56395 2
... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...
... I Clinical Data and Additional Preclinical Results for Non-Nucleoside ... Polymerase Inhibitor Being Presented at AASLD, SAN DIEGO, Nov. ... the results of a Phase I clinical trial,of ANA598 in ... of the leading non-nucleoside polymerase inhibitors,currently in development for the ...
Other Medicine Technology:Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers 2Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers 3Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers 4Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers 5Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers 6
The dryer is designed to rapidly dry slides by blowing warm air over the surface of the slides. The slide dryer accommodates two slide racks directly from a stainer and allows the slides to be staine...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
... have a positive and negative inoculated well, ... these slides, perform QC and sample staining ... education and training programs by testing QC ... on one slide! KWIK-QC slides contain the ...
... Well Plate Capability The Equalizer 384 ... Equalizerexpandable and equal tip spacing, choice of two ... In addition, this model allows you to evenly ... and accessing many gels and for use with ...
Medicine Products: